Cellectis, Janssen, and others plunge into cell therapy with the help of several genome-editing technologies, including TALENs and CRISPR/Cas9.
NIH Director Francis Collins today posted a position statement outlining a policy not to fund any use of gene editing technologies in human embryos.
Scientists from Emory University have found that Cas9 from Francisella novicida can inhibit viral protein production.
The data show that Phytophthora pathogens evolved effectors that bind to a conserved plant protein that controls small RNA biogenesis and processing.
The unique characteristics of mitochondrial genomes and diseases add a twist to the current discussions about heritable edits to the genome.
In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.
Changing the fat and fiber content of people's diets affects their gut microbiome, metabolome, and colon cancer risk, researchers say.
Broken links are found throughout academic publications, and some services are trying to combat such link decay.
Nick Stockton at Wired says that a pause in studying genome-editing tools should be used to find a path forward.